Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04TBC
|
|||
Former ID |
DIB015640
|
|||
Drug Name |
OZ-439
|
|||
Synonyms |
Oral quick release synthetic trioxolane (Plasmodium infections), MMV/UNMC/STPI/Monash University
Click to Show/Hide
|
|||
Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 2 | [1] | |
Company |
Medicines for Malaria Venture
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H39NO5
|
|||
Canonical SMILES |
C1CC2(CCC1C3=CC=C(C=C3)OCCN4CCOCC4)OC5(C6CC7CC(C6)CC5C7)OO2
|
|||
InChI |
1S/C28H39NO5/c1-3-26(31-14-11-29-9-12-30-13-10-29)4-2-22(1)23-5-7-27(8-6-23)32-28(34-33-27)24-16-20-15-21(18-24)19-25(28)17-20/h1-4,20-21,23-25H,5-19H2
|
|||
InChIKey |
XLCNVWUKICLURR-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1029939-86-3
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02083380) Phase IIb Study to Investigate the Efficacy of OZ439 & Piperaquine Phosphate Co-administered to Adults & Children With Uncomplicated Plasmodium Falciparum.. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.